An Exploratory Pilot Study Evaluating Various Diagnostic Measurements Taken During an Escalating Dose Oral Food Challenge to Patient Response

ORA, Inc.1 site in 1 country6 target enrollmentMarch 2016

ConditionsFood Hypersensitivity

Overview

Phase: N/A
Intervention: Not specified
Conditions: Food Hypersensitivity
Sponsor: ORA, Inc.
Enrollment: 6
Locations: 1
Primary Endpoint: Correlation between objective biomarker measures and challenge outcome
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to correlate various diagnostic measurements taken during an escalating dose oral food challenge to the subject's response. This study will investigate whether non invasive objective biomarkers can indicate a positive response to an escalating dose OFC before a systemic reaction occurs.

Detailed Description

Patients often discover their food allergies after consuming a given food and experiencing a subsequent allergic reaction. The majority of patients (75%) will then consult a food allergist for formal diagnosis and treatment information. With respect to patient quality of life, there is tremendous benefit in having a confirmed diagnosis of food allergy as often patients are unsure of the source of their reaction outside the office. Allergists will conduct a Skin Prick Test (SPT) and assess serum specific IgE levels to screen for specific food protein sensitivities. However, a positive response in SPT and specific IgE will confirm only sensitivity, and in more than 70% of cases patients that respond positively to SPT and specific IgE testing will NOT manifest an allergic response to food consumption. To address this issue, most food allergists will recommend an oral food challenge in a controlled setting to confirm the allergic response from consuming the suspected foods. The oral food challenge (OFC) consists of consuming escalating levels of the suspect food, (usually mixed in applesauce or controlled baked goods), until either a reaction manifests or until the challenge is complete with no reaction. The food challenge process poses significant risk to the patient. In 5% of cases, the patient experiences a severe allergic response which requires the use of epinephrine. These responses typically consist of severe reactions in GI or respiratory and arise from challenging patients with higher doses of food allergen then is necessary to prove a mild allergic response, which is directly linked to variability in diagnosis of a positive response, within subjects and within investigators. The investigators hypothesize that measurements taken using minimally-invasive diagnostic tests during the course of an escalating-dose oral food challenge will be able to detect a positive response before a systemic reaction occurs in the patient and may be able to screen with individuals predisposed to EOE.

Registry

clinicaltrials.gov

Start Date

March 2016

End Date

October 2016

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

ORA, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Male or female of any race, aged 5 - 35 years with planned clinical oral food challenge;
•Have provided verbal and written informed consent. If under the age of 18, a parent/guardian must provide verbal and written informed consent;
•Be willing and able to follow instructions, including participation in study assessments, and can be present for the required study visits for the duration of the study;